1. Home
  2. Labeler Index
  3. Deseret Biologicals, Inc.
  4. NDC Product Code: 43742-2193 Vir Combination

NDC 43742-2193 Vir Combination

Adenoviren Nosode,Cytomegalovirus Nosode,Herpes Simplex Virus 1 Dna,Herpes Simplex Virus 2 - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 43742-2193?
  4. Vir Combination Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. Pharmacologic Classes

Product Information

Get all the details for National Drug Code (NDC) 43742-2193 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.

NDC Product Code:
43742-2193
Proprietary Name:
Vir Combination
Non-Proprietary Name: [1]
Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 Dna, Herpes Simplex Virus 2 Dna, Epstein-barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6a, Human Herpesvirus 6b, Influenzinum (2023-2024)
Substance Name: [2]
Hepatitis B Virus; Herring Sperm Dna; Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen; Human Herpesvirus 1; Human Herpesvirus 2; Human Herpesvirus 4; Human Herpesvirus 5; Human Herpesvirus 6; Influenza A Virus A/darwin/6/2021 (h3n2) Whole; Influenza A Virus Whole; Influenza B Virus B/austria/1359417/2021 Bvr-26 Whole; Influenza B Virus B/phuket/3073/2013 Bvr-1b Whole
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route(s): [4]
Oral - Administration to or by way of the mouth.
Labeler Name: [5]
Deseret Biologicals, Inc.
Labeler Code:
43742
Product Label ID:
dcc97028-0bd4-45d4-8635-5d4ca9114f06
Marketing Category: [8]
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date: [9]
08-26-2024
End Marketing Date: [10]
02-12-2030
Exclude Flag: [12]
N
Code Navigator:

Code Structure Chart

Product Details

What is NDC 43742-2193?

The NDC code 43742-2193 is assigned by the FDA to the product Vir Combination which is a human over the counter drug product labeled by Deseret Biologicals, Inc.. The generic name of Vir Combination is adenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum (2023-2024). The product's dosage form is liquid and is administered via oral form. The product is distributed in a single package with assigned NDC code 43742-2193-1 30 ml in 1 bottle, dropper . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Vir Combination?

1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

What are Vir Combination Active Ingredients?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Which are Vir Combination UNII Codes?

The UNII codes for the active ingredients in this product are:

  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN (UNII: FKD3DUK39I)
  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 (UNII: FKD3DUK39I) (Active Moiety)
  • HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K)
  • HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K) (Active Moiety)
  • HERRING SPERM DNA (UNII: 51FI676N6F)
  • HERRING SPERM DNA (UNII: 51FI676N6F) (Active Moiety)
  • HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX)
  • HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (Active Moiety)
  • HEPATITIS B VIRUS (UNII: 77H9EM77P7)
  • HEPATITIS B VIRUS (UNII: 77H9EM77P7) (Active Moiety)
  • HUMAN HERPESVIRUS 1 (UNII: 22G38P19RL)
  • HUMAN HERPESVIRUS 1 (UNII: 22G38P19RL) (Active Moiety)
  • HUMAN HERPESVIRUS 2 (UNII: 74J6DNH49U)
  • HUMAN HERPESVIRUS 2 (UNII: 74J6DNH49U) (Active Moiety)
  • HUMAN HERPESVIRUS 6 (UNII: 4IX4VP35CR)
  • HUMAN HERPESVIRUS 6 (UNII: 4IX4VP35CR) (Active Moiety)
  • INFLUENZA A VIRUS WHOLE (UNII: R9HH0NDE2E)
  • INFLUENZA A VIRUS WHOLE (UNII: R9HH0NDE2E) (Active Moiety)
  • INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE (UNII: PMY5J4Z7LS)
  • INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE (UNII: PMY5J4Z7LS) (Active Moiety)
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE (UNII: CYK5P89K8X)
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE (UNII: CYK5P89K8X) (Active Moiety)
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE (UNII: PS2DCE2WVF)
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE (UNII: PS2DCE2WVF) (Active Moiety)

Which are Vir Combination Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

Which are the Pharmacologic Classes for Vir Combination?

A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

* Please review the disclaimer below.

Product Footnotes

[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".